Sentences with phrase «psa levels»

With the help of my doctor I tested a theory that sex would cause my PSA levels to go up even after the surgery (Urologist later confirmed that he had left minute piece of Prostate after the surgery).

High PSA levels can be an indicator of prostate issues, including cancer.

We've helped thousands of people apply for term life insurance, and many of those people had high PSA levels.

Life insurance companies look at PSA levels when you apply for term life insurance.

According to the study, 126 men were diagnosed with prostate cancer, and of those, 90 percent of deaths occurred in men in the top 25 percent of PSA levels at age 60.

The researchers concluded that men with PSA levels in this range, which is about half of all men, should be considered at low risk of prostate cancer death and may not need to be screened in the future.

I was diagnosed — through a number of tests beyond PSA levels — with an aggressive prostate cancer, which has been successfully treated by surgery.

The PSA levels decreased signifi - cantly in 3 of the 18 patients.

Contrary to the medical preference of chemically castrating men with prostate cancer, research with boron has shown that elevated testosterone levels are beneficial by shrinking prostate tumours and PSA levels, PSA being a marker for tumours and inflammation in the prostate.

Several studies show smaller tumors, more cancer cell death, and lower PSA levels.

PSA levels are measured to monitor how well prostate cancer treatment is working.

In men with prostate cancer, those who drank pomegranate juice significantly lengthened the time it took for their PSA levels to double (from about 15 months to 54 months).

Doctors look for higher than normal amounts of PSA levels which can often be an indication of prostate cancer.

If simply drinking pomegranate juice on a daily basis can stabilize PSA levels, then it's possible that cancer could be prevented at some point in time (possibly!).

Helps to modulate healthy PSA levels, reduce inflammation, and increase cell health for reduced prostate discomfort.

In fact, in two of the men, their PSA levels dropped so much, they didn't even have to go through with the second biopsy at all.

Significant drop in PSA levels (which is a biomarker of prostate cell growth); a drop in cholesterol (which is what we'd expect with a lower - fat diet, and all that extra fiber); and, importantly, a significant decrease in the cellular proliferation rate.

For older men or those currently suffering from prostate issues, they'll be thrilled to know that LGD - 4033 doesn't have direct influence on PSA levels.

Prostate cancer this drug — Enzalutamide had been recommended for father's prostate cancer PSA levels are rising rapidly.

PSA levels are rising rapidly.

These blood PSA levels are used as part of routine screening to assess a man's risk for prostate cancer.

Specifically, in patients with BRCA alterations, the emergence of these reversions at very low PSA levels may allow for switching to non-PARPi and non — platinum - based therapies earlier in the course of disease progression.

Examples of biomarkers commonly used in medicine today include cardiac troponin T for heart attacks and PSA levels in prostate cancer.

Higher PSA levels can also be caused by other conditions, like inflammation of the prostate or enlarged prostate.

Fry — rightly respected for his scientific knowledge and rationality — said «I would urge any of you men of a certain age to think about getting your PSA levels checked».

«Moreover, only 25 percent of men with raised PSA levels that have a biopsy actually have prostate cancer.

High PSA levels are often followed by a biopsy to confirm the presence of cancer, and whether it's slow growing or aggressive.

MRI technology was used to identify and locate a probably tumor (outlined in yellow) during a targeted prostate biopsy for a patient who had previously had multiple negative biopsies but had persistently high PSA levels.

Although some experts question Stamey's interpretation of the data, his skepticism about the meaning of PSA levels has significant support.

The study included questions on BPH - related outcomes, including enlarged prostate, elevated PSA levels and nocturia.

«Our main finding is that even at extremely low PSA levels (< 0.5), PSMA was able to detect sites of possible recurrence in 50 percent of patients while FMC detected possible recurrence in only 12.5 percent,» Morigi states.

«We specifically addressed men with prostate cancer and low PSA levels, at which current imaging techniques struggle in detecting disease.»

Men who showed decreases in PSA levels after three cycles were continued on testosterone injections alone.

Of the 14 remaining in the trial, seven experienced a dip in their PSA levels of between 30 and 99 percent, an indication their cancers were stable or lessening in severity.

«The phi test helps physicians distinguish prostate cancer from benign conditions by utilizing three different PSA markers (PSA, freePSA and p2PSA) as part of a sophisticated algorithm to more reliably determine the probability of cancer in patients with elevated PSA levels,» said Kevin Slawin, MD, director, Vanguard Urologic Institute at Memorial Hermann Medical Group, clinical professor of Urology at Baylor College of Medicine and director of Urology, Memorial Hermann Hospital ‐ Texas Medical Center, who performed some of the key research that led to the development of the phi test and who also began using the test in February.

«Based on the PSA levels, many patients underwent a biopsy and prostatectomy,» explained Popescu.

«After prostatectomy serum PSA levels go to nearly zero because it is produced almost exclusively in the prostate.

The screening has a high false positive rate because PSA levels rise from nonmalignant prostate growth.

To develop the nomogram, the researchers created a virtual population model representing U.S. men aged 50 to 84 years from 1975 to 2005 and applied existing data on PSA levels, biopsy practices and cancer diagnosis patterns to learn about cancer progression in patients with and without screening.

But up to 30 to 40 percent of these patients experience rising PSA levels after surgery, and these patients are often treated using radiation therapy.

A new study has identified a group of molecules in prostate - cancer cells that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels indicate their cancer has recurred after surgical removal of the prostate.

This study analyzed preserved tumor samples from 43 prostate cancer patients who later received radiation therapy after rising PSA levels were detected following a radical prostatectomy.

Associate professor Mary - Ellen Taplin, of the Dana - Farber Cancer Institute, Boston, USA, will tell the 26th EORTC - NCI - AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, that galeterone was well tolerated by patients in the ARMOR2 trial, and also lowered PSA levels in a subset of men with CRPC that was resistant to other drugs that target the cancer, such as enzalutamide and abiraterone.

PSA levels declined by 30 % or more (PSA30) in 50 out of 60 (83 %) patients, of whom 42 (70 %) went on to have declines of 50 % or more (PSA50).

His oncologist confirms that his PSA level is pleasingly low.

Emmett points out, «The results of the study show that PSMA PET is more predictive of a treatment response than PSA level, surgical margins or seminal vesical involvement.»

They came up with a prediction model which estimates that the likelihood of over-diagnosis ranges from 2.9 to 88.1 percent depending on patient age, PSA level and Gleason score at diagnosis.

Eligible patients presented with tumor stages of T1c to T3a, prostate - specific androgen (PSA) levels of 20 or below, and one or two of three risk factors: stage T3a, a Gleason tumor score of seven or higher, or a PSA level greater than 10.

If 1,000 men get PSA screening (cost: roughly $ 40), 240 will be told their PSA level suggests cancer might be present.

Because of the increase in screening and detection of prostate cancer over the past two decades, he now says a higher PSA level may most often reflect a harmless age - related increase in prostate size.